Clinical Trial

A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults

Name: A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults — clinical trial record (NCT05389319)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label, first-in-human, dose-finding study to evaluate the safety and immunogenicity of a booster vaccination of Prime-2-CoV\_Beta in healthy participants.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-16

Trial Details

NCT Number	NCT05389319
Lead Sponsor	University Hospital Tuebingen Collaborators: FGK Clinical Research GmbH, VisMederi srl, Staburo GmbH, Viedoc Technologies AB
Conditions	COVID-19
Enrollment	96 participants
Start Date	2022-06-24
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-15